Borrelia infection and pityriasis rosea

Acta Dermato-Venereologica

Volumn 89, Issue 1, 2009, Pages 97-98

  Stinco, Giuseppe ^a   Ruscio, Maurizio ^b   Proscia, Davide ^a   Piccirillo, Fabio ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b Hospital of San Daniele del Friuli   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; RIFAMPICIN;

ADULT; ANAMNESIS; BACTERIUM CULTURE; BACTERIUM ISOLATION; BLOOD CELL COUNT; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; BORRELIA INFECTION; CASE REPORT; DISEASE SEVERITY; EPIDERMIS HYPERPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LETTER; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PHYSICAL EXAMINATION; PITYRIASIS ROSEA; PRIORITY JOURNAL; SKIN BIOPSY; SKIN EDEMA; SKIN MANIFESTATION; TREATMENT DURATION;

BORRELIA INFECTIONS; HUMANS; MALE; PITYRIASIS ROSEA; YOUNG ADULT;

EID: 58549097131     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0544     Document Type: Letter

References (7)

1. González LM, Allen R, Janniger CK, Schwartz RA. Pityriasis rosea: an important papulosquamous disorder. Int J Dermatol 2005; 44: 757-764.
2. Chuh A, Chan H, Zawar V. Pityriasis rosea - evidence for and against an infectious aetiology. Epidemiol Infect 2004; 132: 381-390.
3. Kempf W, Burg G. Pityriasis rosea - a virus induced skin disease? An update. Arch Virol 2000; 145: 1509-1520.
4. Trevisan G, Cinco M, Agolzer A. Roseolar lesions in Lyme disease: isolation of the causative agent. Int J Dermatol 1992; 31: 507-508.
5. Aberer E. The dermatologic spectrum of Lyme borreliosis. Wien Med Wochenschr 1995; 145: 165-170.
6. Mullegger RR. Dermatological manifestations of Lyme borreliosis. Eur J Dermatol 2004; 14: 296-309.
7. Benedix F, Weide B, Broekaert S, Metzler G, Frick JS, Burgdorf WH, et al. Early disseminated borreliosis with multiple erythema migrans and elevated liver enzymes: case report and literature review. Acta Derm Venereol 2007; 87: 418-421.